Dynastat
parecoxib
Table of contents
Overview
Dynastat is a painkilling medicine for use in adults for the short-term relief of pain after an operation.
It contains the active substance parecoxib.
Authorisation details
Product details | |
---|---|
Name |
Dynastat
|
Agency product number |
EMEA/H/C/000381
|
Active substance |
parecoxib sodium
|
International non-proprietary name (INN) or common name |
parecoxib
|
Therapeutic area (MeSH) |
Pain, Postoperative
|
Anatomical therapeutic chemical (ATC) code |
M01AH04
|
Publication details | |
---|---|
Marketing-authorisation holder |
Pfizer Europe MA EEIG
|
Revision |
32
|
Date of issue of marketing authorisation valid throughout the European Union |
22/03/2002
|
Contact address |
Boulevard de la Plaine 17 |
Product information
16/06/2022 Dynastat - EMEA/H/C/000381 - II/0085
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Antiinflammatory and antirheumatic products
-
Coxibs
Therapeutic indication
For the short-term treatment of postoperative pain in adults.